Motif 691 (n=49)
Position-wise Probabilities
Download
uniprot | genes | site | source | protein | function |
---|---|---|---|---|---|
P0CG47 | UBB | S20 | ochoa | Polyubiquitin-B [Cleaved into: Ubiquitin] | [Ubiquitin]: Exists either covalently attached to another protein, or free (unanchored). When covalently bound, it is conjugated to target proteins via an isopeptide bond either as a monomer (monoubiquitin), a polymer linked via different Lys residues of the ubiquitin (polyubiquitin chains) or a linear polymer linked via the initiator Met of the ubiquitin (linear polyubiquitin chains). Polyubiquitin chains, when attached to a target protein, have different functions depending on the Lys residue of the ubiquitin that is linked: Lys-6-linked may be involved in DNA repair; Lys-11-linked is involved in ERAD (endoplasmic reticulum-associated degradation) and in cell-cycle regulation; Lys-29-linked is involved in proteotoxic stress response and cell cycle; Lys-33-linked is involved in kinase modification; Lys-48-linked is involved in protein degradation via the proteasome; Lys-63-linked is involved in endocytosis, DNA-damage responses as well as in signaling processes leading to activation of the transcription factor NF-kappa-B. Linear polymer chains formed via attachment by the initiator Met lead to cell signaling. Ubiquitin is usually conjugated to Lys residues of target proteins, however, in rare cases, conjugation to Cys or Ser residues has been observed. When polyubiquitin is free (unanchored-polyubiquitin), it also has distinct roles, such as in activation of protein kinases, and in signaling. {ECO:0000269|PubMed:16543144, ECO:0000269|PubMed:34239127, ECO:0000303|PubMed:19754430}. |
P0CG48 | UBC | S20 | ochoa | Polyubiquitin-C [Cleaved into: Ubiquitin] | [Ubiquitin]: Exists either covalently attached to another protein, or free (unanchored). When covalently bound, it is conjugated to target proteins via an isopeptide bond either as a monomer (monoubiquitin), a polymer linked via different Lys residues of the ubiquitin (polyubiquitin chains) or a linear polymer linked via the initiator Met of the ubiquitin (linear polyubiquitin chains). Polyubiquitin chains, when attached to a target protein, have different functions depending on the Lys residue of the ubiquitin that is linked: Lys-6-linked may be involved in DNA repair; Lys-11-linked is involved in ERAD (endoplasmic reticulum-associated degradation) and in cell-cycle regulation; Lys-29-linked is involved in proteotoxic stress response and cell cycle; Lys-33-linked is involved in kinase modification; Lys-48-linked is involved in protein degradation via the proteasome; Lys-63-linked is involved in endocytosis, DNA-damage responses as well as in signaling processes leading to activation of the transcription factor NF-kappa-B. Linear polymer chains formed via attachment by the initiator Met lead to cell signaling. Ubiquitin is usually conjugated to Lys residues of target proteins, however, in rare cases, conjugation to Cys or Ser residues has been observed. When polyubiquitin is free (unanchored-polyubiquitin), it also has distinct roles, such as in activation of protein kinases, and in signaling. During ubiquitination, the acceptor ubiquitin is positioned in the active site via direct interaction with the E2 ubiquitin-conjugating enzymes such as UBE2R2 (PubMed:38326650). As a monoubiquitin, its C-terminal glycine is recognized as a C-degron by Cul2-RING (CRL2) E3 ubiquitin-protein ligase complexes (PubMed:39548056). {ECO:0000269|PubMed:16543144, ECO:0000269|PubMed:34239127, ECO:0000269|PubMed:38326650, ECO:0000269|PubMed:39548056, ECO:0000303|PubMed:19754430}. |
P62979 | RPS27A | S20 | ochoa | Ubiquitin-ribosomal protein eS31 fusion protein (Ubiquitin carboxyl extension protein 80) [Cleaved into: Ubiquitin; Small ribosomal subunit protein eS31 (40S ribosomal protein S27a)] | [Ubiquitin]: Exists either covalently attached to another protein, or free (unanchored). When covalently bound, it is conjugated to target proteins via an isopeptide bond either as a monomer (monoubiquitin), a polymer linked via different Lys residues of the ubiquitin (polyubiquitin chains) or a linear polymer linked via the initiator Met of the ubiquitin (linear polyubiquitin chains). Polyubiquitin chains, when attached to a target protein, have different functions depending on the Lys residue of the ubiquitin that is linked: Lys-6-linked may be involved in DNA repair; Lys-11-linked is involved in ERAD (endoplasmic reticulum-associated degradation) and in cell-cycle regulation; Lys-29-linked is involved in proteotoxic stress response and cell cycle; Lys-33-linked is involved in kinase modification; Lys-48-linked is involved in protein degradation via the proteasome; Lys-63-linked is involved in endocytosis, DNA-damage responses as well as in signaling processes leading to activation of the transcription factor NF-kappa-B. Linear polymer chains formed via attachment by the initiator Met lead to cell signaling. Ubiquitin is usually conjugated to Lys residues of target proteins, however, in rare cases, conjugation to Cys or Ser residues has been observed. When polyubiquitin is free (unanchored-polyubiquitin), it also has distinct roles, such as in activation of protein kinases, and in signaling. {ECO:0000269|PubMed:16543144, ECO:0000269|PubMed:34239127, ECO:0000303|PubMed:19754430}.; FUNCTION: [Small ribosomal subunit protein eS31]: Component of the 40S subunit of the ribosome (PubMed:23636399, PubMed:9582194). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome (PubMed:23636399, PubMed:34516797). {ECO:0000269|PubMed:23636399, ECO:0000269|PubMed:34516797, ECO:0000305|PubMed:9582194}. |
P62987 | UBA52 | S20 | ochoa | Ubiquitin-ribosomal protein eL40 fusion protein (CEP52) (Ubiquitin A-52 residue ribosomal protein fusion product 1) [Cleaved into: Ubiquitin; Large ribosomal subunit protein eL40 (60S ribosomal protein L40) (rpL40)] | [Ubiquitin]: Exists either covalently attached to another protein, or free (unanchored). When covalently bound, it is conjugated to target proteins via an isopeptide bond either as a monomer (monoubiquitin), a polymer linked via different Lys residues of the ubiquitin (polyubiquitin chains) or a linear polymer linked via the initiator Met of the ubiquitin (linear polyubiquitin chains). Polyubiquitin chains, when attached to a target protein, have different functions depending on the Lys residue of the ubiquitin that is linked: Lys-6-linked may be involved in DNA repair; Lys-11-linked is involved in ERAD (endoplasmic reticulum-associated degradation) and in cell-cycle regulation; Lys-29-linked is involved in proteotoxic stress response and cell cycle; Lys-33-linked is involved in kinase modification; Lys-48-linked is involved in protein degradation via the proteasome; Lys-63-linked is involved in endocytosis, DNA-damage responses as well as in signaling processes leading to activation of the transcription factor NF-kappa-B. Linear polymer chains formed via attachment by the initiator Met lead to cell signaling. Ubiquitin is usually conjugated to Lys residues of target proteins, however, in rare cases, conjugation to Cys or Ser residues has been observed. When polyubiquitin is free (unanchored-polyubiquitin), it also has distinct roles, such as in activation of protein kinases, and in signaling. {ECO:0000269|PubMed:16543144, ECO:0000269|PubMed:34239127, ECO:0000303|PubMed:19754430}.; FUNCTION: [Large ribosomal subunit protein eL40]: Component of the 60S subunit of the ribosome (PubMed:23169626, PubMed:23636399, PubMed:32669547, PubMed:39048817, PubMed:39103523). Ribosomal protein L40 is essential for translation of a subset of cellular transcripts, and especially for cap-dependent translation of vesicular stomatitis virus mRNAs (PubMed:23169626, PubMed:23636399, PubMed:32669547, PubMed:39048817, PubMed:39103523). {ECO:0000269|PubMed:23169626, ECO:0000269|PubMed:23636399, ECO:0000269|PubMed:32669547, ECO:0000269|PubMed:39048817, ECO:0000269|PubMed:39103523}. |
Q09666 | AHNAK | T590 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S613 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | T651 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S660 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | T718 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S781 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S793 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S1023 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S1042 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S1170 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S1298 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S1344 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | T1472 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S1542 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S1744 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S1802 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | T1885 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S2138 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | T2147 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S2423 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S2542 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S2600 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S2670 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S2926 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S2984 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S3054 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S3112 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S3240 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | T3625 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S3634 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S4092 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S4220 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S4360 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S4614 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S4803 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S4812 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S4870 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S5190 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S5293 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S5318 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S5620 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q8IVF2 | AHNAK2 | S1198 | ochoa | Protein AHNAK2 | None |
Q8IVF2 | AHNAK2 | S2179 | ochoa | Protein AHNAK2 | None |
Q8IVF2 | AHNAK2 | S4324 | ochoa | Protein AHNAK2 | None |
Q8IVF2 | AHNAK2 | S4425 | ochoa | Protein AHNAK2 | None |
Download
reactome_id | name | p | -log10_p |
---|---|---|---|
R-HSA-9706377 | FLT3 signaling by CBL mutants | 2.496114e-12 | 11.603 |
R-HSA-9683683 | Maturation of protein E | 4.257372e-12 | 11.371 |
R-HSA-9694493 | Maturation of protein E | 4.257372e-12 | 11.371 |
R-HSA-937042 | IRAK2 mediated activation of TAK1 complex | 2.153577e-11 | 10.667 |
R-HSA-9828211 | Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | 1.520872e-11 | 10.818 |
R-HSA-8948747 | Regulation of PTEN localization | 1.038980e-11 | 10.983 |
R-HSA-3785653 | Myoclonic epilepsy of Lafora | 1.520872e-11 | 10.818 |
R-HSA-1253288 | Downregulation of ERBB4 signaling | 1.520872e-11 | 10.818 |
R-HSA-9637628 | Modulation by Mtb of host immune system | 1.520872e-11 | 10.818 |
R-HSA-8849469 | PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | 1.520872e-11 | 10.818 |
R-HSA-9014325 | TICAM1,TRAF6-dependent induction of TAK1 complex | 2.965661e-11 | 10.528 |
R-HSA-5689877 | Josephin domain DUBs | 2.965661e-11 | 10.528 |
R-HSA-9664873 | Pexophagy | 2.965661e-11 | 10.528 |
R-HSA-9824878 | Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | 5.254619e-11 | 10.279 |
R-HSA-1358803 | Downregulation of ERBB2:ERBB3 signaling | 6.800949e-11 | 10.167 |
R-HSA-9645460 | Alpha-protein kinase 1 signaling pathway | 3.988176e-11 | 10.399 |
R-HSA-2691232 | Constitutive Signaling by NOTCH1 HD Domain Mutants | 6.800949e-11 | 10.167 |
R-HSA-2691230 | Signaling by NOTCH1 HD Domain Mutants in Cancer | 6.800949e-11 | 10.167 |
R-HSA-9013973 | TICAM1-dependent activation of IRF3/IRF7 | 5.254619e-11 | 10.279 |
R-HSA-209560 | NF-kB is activated and signals survival | 5.254619e-11 | 10.279 |
R-HSA-937039 | IRAK1 recruits IKK complex | 6.800949e-11 | 10.167 |
R-HSA-8866427 | VLDLR internalisation and degradation | 6.800949e-11 | 10.167 |
R-HSA-975144 | IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | 6.800949e-11 | 10.167 |
R-HSA-8876493 | InlA-mediated entry of Listeria monocytogenes into host cells | 3.988176e-11 | 10.399 |
R-HSA-209543 | p75NTR recruits signalling complexes | 6.800949e-11 | 10.167 |
R-HSA-937072 | TRAF6-mediated induction of TAK1 complex within TLR4 complex | 1.351590e-10 | 9.869 |
R-HSA-975163 | IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | 1.088947e-10 | 9.963 |
R-HSA-110312 | Translesion synthesis by REV1 | 1.351590e-10 | 9.869 |
R-HSA-174490 | Membrane binding and targetting of GAG proteins | 8.665602e-11 | 10.062 |
R-HSA-174495 | Synthesis And Processing Of GAG, GAGPOL Polyproteins | 1.088947e-10 | 9.963 |
R-HSA-205043 | NRIF signals cell death from the nucleus | 1.088947e-10 | 9.963 |
R-HSA-8875360 | InlB-mediated entry of Listeria monocytogenes into host cell | 1.351590e-10 | 9.869 |
R-HSA-2173791 | TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | 1.351590e-10 | 9.869 |
R-HSA-168927 | TICAM1, RIP1-mediated IKK complex recruitment | 1.351590e-10 | 9.869 |
R-HSA-5684264 | MAP3K8 (TPL2)-dependent MAPK1/3 activation | 1.088947e-10 | 9.963 |
R-HSA-1295596 | Spry regulation of FGF signaling | 1.351590e-10 | 9.869 |
R-HSA-193639 | p75NTR signals via NF-kB | 1.351590e-10 | 9.869 |
R-HSA-5656121 | Translesion synthesis by POLI | 1.659067e-10 | 9.780 |
R-HSA-9758274 | Regulation of NF-kappa B signaling | 1.659067e-10 | 9.780 |
R-HSA-9708530 | Regulation of BACH1 activity | 1.659067e-10 | 9.780 |
R-HSA-9706369 | Negative regulation of FLT3 | 1.659067e-10 | 9.780 |
R-HSA-5655862 | Translesion synthesis by POLK | 2.016206e-10 | 9.695 |
R-HSA-3134975 | Regulation of innate immune responses to cytosolic DNA | 2.016206e-10 | 9.695 |
R-HSA-936964 | Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | 2.016206e-10 | 9.695 |
R-HSA-975110 | TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | 2.016206e-10 | 9.695 |
R-HSA-4641263 | Regulation of FZD by ubiquitination | 2.428074e-10 | 9.615 |
R-HSA-3229121 | Glycogen storage diseases | 2.428074e-10 | 9.615 |
R-HSA-9613829 | Chaperone Mediated Autophagy | 2.899988e-10 | 9.538 |
R-HSA-6804760 | Regulation of TP53 Activity through Methylation | 2.899988e-10 | 9.538 |
R-HSA-110320 | Translesion Synthesis by POLH | 3.437506e-10 | 9.464 |
R-HSA-174048 | APC/C:Cdc20 mediated degradation of Cyclin B | 3.437506e-10 | 9.464 |
R-HSA-937041 | IKK complex recruitment mediated by RIP1 | 3.437506e-10 | 9.464 |
R-HSA-912631 | Regulation of signaling by CBL | 3.437506e-10 | 9.464 |
R-HSA-5696397 | Gap-filling DNA repair synthesis and ligation in GG-NER | 5.502935e-10 | 9.259 |
R-HSA-179409 | APC-Cdc20 mediated degradation of Nek2A | 4.732811e-10 | 9.325 |
R-HSA-450321 | JNK (c-Jun kinases) phosphorylation and activation mediated by activated human ... | 4.732811e-10 | 9.325 |
R-HSA-8876384 | Listeria monocytogenes entry into host cells | 5.502935e-10 | 9.259 |
R-HSA-6807004 | Negative regulation of MET activity | 4.046431e-10 | 9.393 |
R-HSA-175474 | Assembly Of The HIV Virion | 5.502935e-10 | 9.259 |
R-HSA-450302 | activated TAK1 mediates p38 MAPK activation | 5.502935e-10 | 9.259 |
R-HSA-9636383 | Prevention of phagosomal-lysosomal fusion | 4.732811e-10 | 9.325 |
R-HSA-2979096 | NOTCH2 Activation and Transmission of Signal to the Nucleus | 4.732811e-10 | 9.325 |
R-HSA-9931295 | PD-L1(CD274) glycosylation and translocation to plasma membrane | 4.732811e-10 | 9.325 |
R-HSA-9705462 | Inactivation of CSF3 (G-CSF) signaling | 5.502935e-10 | 9.259 |
R-HSA-3322077 | Glycogen synthesis | 4.046431e-10 | 9.393 |
R-HSA-5637815 | Signaling by Ligand-Responsive EGFR Variants in Cancer | 4.732811e-10 | 9.325 |
R-HSA-1236382 | Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | 4.732811e-10 | 9.325 |
R-HSA-2173788 | Downregulation of TGF-beta receptor signaling | 6.363339e-10 | 9.196 |
R-HSA-9013507 | NOTCH3 Activation and Transmission of Signal to the Nucleus | 6.363339e-10 | 9.196 |
R-HSA-9954716 | ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ri... | 6.493858e-10 | 9.187 |
R-HSA-110314 | Recognition of DNA damage by PCNA-containing replication complex | 8.382337e-10 | 9.077 |
R-HSA-5689901 | Metalloprotease DUBs | 1.084694e-09 | 8.965 |
R-HSA-2122948 | Activated NOTCH1 Transmits Signal to the Nucleus | 1.084694e-09 | 8.965 |
R-HSA-9637687 | Suppression of phagosomal maturation | 1.084694e-09 | 8.965 |
R-HSA-1643713 | Signaling by EGFR in Cancer | 1.084694e-09 | 8.965 |
R-HSA-9692914 | SARS-CoV-1-host interactions | 1.161676e-09 | 8.935 |
R-HSA-8866652 | Synthesis of active ubiquitin: roles of E1 and E2 enzymes | 1.226525e-09 | 8.911 |
R-HSA-917729 | Endosomal Sorting Complex Required For Transport (ESCRT) | 1.551387e-09 | 8.809 |
R-HSA-9615710 | Late endosomal microautophagy | 1.551387e-09 | 8.809 |
R-HSA-5656169 | Termination of translesion DNA synthesis | 1.551387e-09 | 8.809 |
R-HSA-901032 | ER Quality Control Compartment (ERQC) | 1.226525e-09 | 8.911 |
R-HSA-5654732 | Negative regulation of FGFR3 signaling | 1.381815e-09 | 8.860 |
R-HSA-5654733 | Negative regulation of FGFR4 signaling | 1.551387e-09 | 8.809 |
R-HSA-5357956 | TNFR1-induced NF-kappa-B signaling pathway | 1.226525e-09 | 8.911 |
R-HSA-5205685 | PINK1-PRKN Mediated Mitophagy | 1.381815e-09 | 8.860 |
R-HSA-9674555 | Signaling by CSF3 (G-CSF) | 1.551387e-09 | 8.809 |
R-HSA-8863795 | Downregulation of ERBB2 signaling | 1.736087e-09 | 8.760 |
R-HSA-211733 | Regulation of activated PAK-2p34 by proteasome mediated degradation | 1.936788e-09 | 8.713 |
R-HSA-162588 | Budding and maturation of HIV virion | 1.936788e-09 | 8.713 |
R-HSA-936440 | Negative regulators of DDX58/IFIH1 signaling | 1.936788e-09 | 8.713 |
R-HSA-182971 | EGFR downregulation | 1.936788e-09 | 8.713 |
R-HSA-9833109 | Evasion by RSV of host interferon responses | 1.936788e-09 | 8.713 |
R-HSA-2173795 | Downregulation of SMAD2/3:SMAD4 transcriptional activity | 2.154384e-09 | 8.667 |
R-HSA-5675482 | Regulation of necroptotic cell death | 2.389795e-09 | 8.622 |
R-HSA-5654726 | Negative regulation of FGFR1 signaling | 2.389795e-09 | 8.622 |
R-HSA-5696394 | DNA Damage Recognition in GG-NER | 2.643965e-09 | 8.578 |
R-HSA-180534 | Vpu mediated degradation of CD4 | 2.643965e-09 | 8.578 |
R-HSA-5696400 | Dual Incision in GG-NER | 2.917862e-09 | 8.535 |
R-HSA-75815 | Ubiquitin-dependent degradation of Cyclin D | 2.917862e-09 | 8.535 |
R-HSA-349425 | Autodegradation of the E3 ubiquitin ligase COP1 | 2.917862e-09 | 8.535 |
R-HSA-168638 | NOD1/2 Signaling Pathway | 2.917862e-09 | 8.535 |
R-HSA-5654727 | Negative regulation of FGFR2 signaling | 2.917862e-09 | 8.535 |
R-HSA-901042 | Calnexin/calreticulin cycle | 2.917862e-09 | 8.535 |
R-HSA-1980145 | Signaling by NOTCH2 | 2.917862e-09 | 8.535 |
R-HSA-9680350 | Signaling by CSF1 (M-CSF) in myeloid cells | 2.917862e-09 | 8.535 |
R-HSA-5205647 | Mitophagy | 2.917862e-09 | 8.535 |
R-HSA-9948299 | Ribosome-associated quality control | 4.516708e-09 | 8.345 |
R-HSA-8854050 | FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | 3.212477e-09 | 8.493 |
R-HSA-174113 | SCF-beta-TrCP mediated degradation of Emi1 | 3.212477e-09 | 8.493 |
R-HSA-4641258 | Degradation of DVL | 3.867948e-09 | 8.413 |
R-HSA-450408 | AUF1 (hnRNP D0) binds and destabilizes mRNA | 3.528825e-09 | 8.452 |
R-HSA-180585 | Vif-mediated degradation of APOBEC3G | 3.528825e-09 | 8.452 |
R-HSA-5689896 | Ovarian tumor domain proteases | 3.867948e-09 | 8.413 |
R-HSA-4641257 | Degradation of AXIN | 3.867948e-09 | 8.413 |
R-HSA-9762114 | GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | 3.867948e-09 | 8.413 |
R-HSA-9929356 | GSK3B-mediated proteasomal degradation of PD-L1(CD274) | 4.618791e-09 | 8.335 |
R-HSA-169911 | Regulation of Apoptosis | 3.212477e-09 | 8.493 |
R-HSA-69541 | Stabilization of p53 | 4.618791e-09 | 8.335 |
R-HSA-5213460 | RIPK1-mediated regulated necrosis | 4.230907e-09 | 8.374 |
R-HSA-6804757 | Regulation of TP53 Degradation | 3.528825e-09 | 8.452 |
R-HSA-6806003 | Regulation of TP53 Expression and Degradation | 4.618791e-09 | 8.335 |
R-HSA-2173796 | SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | 3.867948e-09 | 8.413 |
R-HSA-3769402 | Deactivation of the beta-catenin transactivating complex | 3.867948e-09 | 8.413 |
R-HSA-2559585 | Oncogene Induced Senescence | 3.212477e-09 | 8.493 |
R-HSA-9648002 | RAS processing | 4.618791e-09 | 8.335 |
R-HSA-8964043 | Plasma lipoprotein clearance | 4.618791e-09 | 8.335 |
R-HSA-9682385 | FLT3 signaling in disease | 3.528825e-09 | 8.452 |
R-HSA-9646399 | Aggrephagy | 5.032710e-09 | 8.298 |
R-HSA-5696395 | Formation of Incision Complex in GG-NER | 5.032710e-09 | 8.298 |
R-HSA-8941858 | Regulation of RUNX3 expression and activity | 5.032710e-09 | 8.298 |
R-HSA-9604323 | Negative regulation of NOTCH4 signaling | 5.032710e-09 | 8.298 |
R-HSA-8982491 | Glycogen metabolism | 5.032710e-09 | 8.298 |
R-HSA-110313 | Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA templa... | 5.473800e-09 | 8.262 |
R-HSA-9929491 | SPOP-mediated proteasomal degradation of PD-L1(CD274) | 5.473800e-09 | 8.262 |
R-HSA-5362768 | Hh mutants are degraded by ERAD | 5.473800e-09 | 8.262 |
R-HSA-5676590 | NIK-->noncanonical NF-kB signaling | 5.473800e-09 | 8.262 |
R-HSA-9607240 | FLT3 Signaling | 5.473800e-09 | 8.262 |
R-HSA-9932298 | Degradation of CRY and PER proteins | 5.943220e-09 | 8.226 |
R-HSA-5610785 | GLI3 is processed to GLI3R by the proteasome | 5.943220e-09 | 8.226 |
R-HSA-5610783 | Degradation of GLI2 by the proteasome | 5.943220e-09 | 8.226 |
R-HSA-5610780 | Degradation of GLI1 by the proteasome | 5.943220e-09 | 8.226 |
R-HSA-5675221 | Negative regulation of MAPK pathway | 5.943220e-09 | 8.226 |
R-HSA-9683701 | Translation of Structural Proteins | 5.943220e-09 | 8.226 |
R-HSA-512988 | Interleukin-3, Interleukin-5 and GM-CSF signaling | 6.442153e-09 | 8.191 |
R-HSA-5387390 | Hh mutants abrogate ligand secretion | 6.971805e-09 | 8.157 |
R-HSA-2173789 | TGF-beta receptor signaling activates SMADs | 6.971805e-09 | 8.157 |
R-HSA-5654743 | Signaling by FGFR4 | 6.971805e-09 | 8.157 |
R-HSA-9637690 | Response of Mtb to phagocytosis | 6.971805e-09 | 8.157 |
R-HSA-9010553 | Regulation of expression of SLITs and ROBOs | 7.151361e-09 | 8.146 |
R-HSA-187577 | SCF(Skp2)-mediated degradation of p27/p21 | 7.533406e-09 | 8.123 |
R-HSA-69231 | Cyclin D associated events in G1 | 7.533406e-09 | 8.123 |
R-HSA-69236 | G1 Phase | 7.533406e-09 | 8.123 |
R-HSA-6783310 | Fanconi Anemia Pathway | 8.128212e-09 | 8.090 |
R-HSA-5678895 | Defective CFTR causes cystic fibrosis | 8.128212e-09 | 8.090 |
R-HSA-5607761 | Dectin-1 mediated noncanonical NF-kB signaling | 8.128212e-09 | 8.090 |
R-HSA-69613 | p53-Independent G1/S DNA Damage Checkpoint | 8.128212e-09 | 8.090 |
R-HSA-69601 | Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | 8.128212e-09 | 8.090 |
R-HSA-4608870 | Asymmetric localization of PCP proteins | 8.128212e-09 | 8.090 |
R-HSA-5654741 | Signaling by FGFR3 | 8.128212e-09 | 8.090 |
R-HSA-174084 | Autodegradation of Cdh1 by Cdh1:APC/C | 8.757498e-09 | 8.058 |
R-HSA-6781823 | Formation of TC-NER Pre-Incision Complex | 8.757498e-09 | 8.058 |
R-HSA-5357905 | Regulation of TNFR1 signaling | 8.757498e-09 | 8.058 |
R-HSA-9861718 | Regulation of pyruvate metabolism | 8.757498e-09 | 8.058 |
R-HSA-174154 | APC/C:Cdc20 mediated degradation of Securin | 9.422568e-09 | 8.026 |
R-HSA-445989 | TAK1-dependent IKK and NF-kappa-B activation | 9.422568e-09 | 8.026 |
R-HSA-2467813 | Separation of Sister Chromatids | 1.003887e-08 | 7.998 |
R-HSA-73893 | DNA Damage Bypass | 1.086538e-08 | 7.964 |
R-HSA-9766229 | Degradation of CDH1 | 1.086538e-08 | 7.964 |
R-HSA-532668 | N-glycan trimming in the ER and Calnexin/Calreticulin cycle | 1.086538e-08 | 7.964 |
R-HSA-69563 | p53-Dependent G1 DNA Damage Response | 1.086538e-08 | 7.964 |
R-HSA-69580 | p53-Dependent G1/S DNA damage checkpoint | 1.086538e-08 | 7.964 |
R-HSA-2122947 | NOTCH1 Intracellular Domain Regulates Transcription | 1.086538e-08 | 7.964 |
R-HSA-8866654 | E3 ubiquitin ligases ubiquitinate target proteins | 1.333187e-08 | 7.875 |
R-HSA-6782210 | Gap-filling DNA repair synthesis and ligation in TC-NER | 1.724486e-08 | 7.763 |
R-HSA-6782135 | Dual incision in TC-NER | 1.949586e-08 | 7.710 |
R-HSA-174184 | Cdc20:Phospho-APC/C mediated degradation of Cyclin A | 1.333187e-08 | 7.875 |
R-HSA-179419 | APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of th... | 1.424029e-08 | 7.846 |
R-HSA-174178 | APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins ... | 1.424029e-08 | 7.846 |
R-HSA-176409 | APC/C:Cdc20 mediated degradation of mitotic proteins | 1.619528e-08 | 7.791 |
R-HSA-9931269 | AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | 1.333187e-08 | 7.875 |
R-HSA-176814 | Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | 1.724486e-08 | 7.763 |
R-HSA-68949 | Orc1 removal from chromatin | 1.333187e-08 | 7.875 |
R-HSA-69017 | CDK-mediated phosphorylation and removal of Cdc6 | 1.519426e-08 | 7.818 |
R-HSA-8948751 | Regulation of PTEN stability and activity | 1.424029e-08 | 7.846 |
R-HSA-9033241 | Peroxisomal protein import | 2.070043e-08 | 7.684 |
R-HSA-1234176 | Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | 1.246753e-08 | 7.904 |
R-HSA-75893 | TNF signaling | 1.724486e-08 | 7.763 |
R-HSA-5658442 | Regulation of RAS by GAPs | 1.164584e-08 | 7.934 |
R-HSA-1169091 | Activation of NF-kappaB in B cells | 1.246753e-08 | 7.904 |
R-HSA-9764561 | Regulation of CDH1 Function | 1.834453e-08 | 7.736 |
R-HSA-2173793 | Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | 1.724486e-08 | 7.763 |
R-HSA-2644603 | Signaling by NOTCH1 in Cancer | 2.195984e-08 | 7.658 |
R-HSA-1227986 | Signaling by ERBB2 | 2.195984e-08 | 7.658 |
R-HSA-5358346 | Hedgehog ligand biogenesis | 1.246753e-08 | 7.904 |
R-HSA-9692916 | SARS-CoV-1 activates/modulates innate immune responses | 1.333187e-08 | 7.875 |
R-HSA-177929 | Signaling by EGFR | 1.724486e-08 | 7.763 |
R-HSA-2644606 | Constitutive Signaling by NOTCH1 PEST Domain Mutants | 2.195984e-08 | 7.658 |
R-HSA-2894862 | Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | 2.195984e-08 | 7.658 |
R-HSA-2644602 | Signaling by NOTCH1 PEST Domain Mutants in Cancer | 2.195984e-08 | 7.658 |
R-HSA-2894858 | Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | 2.195984e-08 | 7.658 |
R-HSA-5693565 | Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at... | 2.070043e-08 | 7.684 |
R-HSA-5654736 | Signaling by FGFR1 | 1.724486e-08 | 7.763 |
R-HSA-9012852 | Signaling by NOTCH3 | 1.619528e-08 | 7.791 |
R-HSA-9678108 | SARS-CoV-1 Infection | 1.378860e-08 | 7.860 |
R-HSA-8939902 | Regulation of RUNX2 expression and activity | 2.327573e-08 | 7.633 |
R-HSA-450294 | MAP kinase activation | 2.327573e-08 | 7.633 |
R-HSA-176408 | Regulation of APC/C activators between G1/S and early anaphase | 2.464975e-08 | 7.608 |
R-HSA-8852276 | The role of GTSE1 in G2/M progression after G2 checkpoint | 2.464975e-08 | 7.608 |
R-HSA-69615 | G1/S DNA Damage Checkpoints | 2.608358e-08 | 7.584 |
R-HSA-8848021 | Signaling by PTK6 | 2.608358e-08 | 7.584 |
R-HSA-9006927 | Signaling by Non-Receptor Tyrosine Kinases | 2.608358e-08 | 7.584 |
R-HSA-376176 | Signaling by ROBO receptors | 2.693823e-08 | 7.570 |
R-HSA-168643 | Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signali... | 2.757892e-08 | 7.559 |
R-HSA-1234174 | Cellular response to hypoxia | 2.913749e-08 | 7.536 |
R-HSA-5693606 | DNA Double Strand Break Response | 3.245134e-08 | 7.489 |
R-HSA-5685942 | HDR through Homologous Recombination (HRR) | 3.245134e-08 | 7.489 |
R-HSA-5218859 | Regulated Necrosis | 3.421018e-08 | 7.466 |
R-HSA-68882 | Mitotic Anaphase | 3.649301e-08 | 7.438 |
R-HSA-2555396 | Mitotic Metaphase and Anaphase | 3.726689e-08 | 7.429 |
R-HSA-1168372 | Downstream signaling events of B Cell Receptor (BCR) | 3.794077e-08 | 7.421 |
R-HSA-195253 | Degradation of beta-catenin by the destruction complex | 3.794077e-08 | 7.421 |
R-HSA-448424 | Interleukin-17 signaling | 3.794077e-08 | 7.421 |
R-HSA-69202 | Cyclin E associated events during G1/S transition | 3.794077e-08 | 7.421 |
R-HSA-1834949 | Cytosolic sensors of pathogen-associated DNA | 3.794077e-08 | 7.421 |
R-HSA-174143 | APC/C-mediated degradation of cell cycle proteins | 3.991623e-08 | 7.399 |
R-HSA-453276 | Regulation of mitotic cell cycle | 3.991623e-08 | 7.399 |
R-HSA-5632684 | Hedgehog 'on' state | 3.991623e-08 | 7.399 |
R-HSA-69656 | Cyclin A:Cdk2-associated events at S phase entry | 4.196764e-08 | 7.377 |
R-HSA-450531 | Regulation of mRNA stability by proteins that bind AU-rich elements | 4.196764e-08 | 7.377 |
R-HSA-69052 | Switching of origins to a post-replicative state | 4.409690e-08 | 7.356 |
R-HSA-204998 | Cell death signalling via NRAGE, NRIF and NADE | 4.409690e-08 | 7.356 |
R-HSA-5663084 | Diseases of carbohydrate metabolism | 4.409690e-08 | 7.356 |
R-HSA-9013694 | Signaling by NOTCH4 | 4.630595e-08 | 7.334 |
R-HSA-1236394 | Signaling by ERBB4 | 4.630595e-08 | 7.334 |
R-HSA-9705683 | SARS-CoV-2-host interactions | 4.667553e-08 | 7.331 |
R-HSA-8852135 | Protein ubiquitination | 4.859674e-08 | 7.313 |
R-HSA-6781827 | Transcription-Coupled Nucleotide Excision Repair (TC-NER) | 4.859674e-08 | 7.313 |
R-HSA-1169408 | ISG15 antiviral mechanism | 4.859674e-08 | 7.313 |
R-HSA-917937 | Iron uptake and transport | 4.859674e-08 | 7.313 |
R-HSA-5689603 | UCH proteinases | 5.097125e-08 | 7.293 |
R-HSA-1980143 | Signaling by NOTCH1 | 5.097125e-08 | 7.293 |
R-HSA-9694635 | Translation of Structural Proteins | 5.343148e-08 | 7.272 |
R-HSA-5619084 | ABC transporter disorders | 5.597946e-08 | 7.252 |
R-HSA-4086400 | PCP/CE pathway | 5.597946e-08 | 7.252 |
R-HSA-5654738 | Signaling by FGFR2 | 6.134686e-08 | 7.212 |
R-HSA-6806834 | Signaling by MET | 6.134686e-08 | 7.212 |
R-HSA-977225 | Amyloid fiber formation | 6.417044e-08 | 7.193 |
R-HSA-5693607 | Processing of DNA double-strand break ends | 6.417044e-08 | 7.193 |
R-HSA-2559582 | Senescence-Associated Secretory Phenotype (SASP) | 6.709009e-08 | 7.173 |
R-HSA-5668541 | TNFR2 non-canonical NF-kB pathway | 7.010795e-08 | 7.154 |
R-HSA-5696399 | Global Genome Nucleotide Excision Repair (GG-NER) | 7.322618e-08 | 7.135 |
R-HSA-8939236 | RUNX1 regulates transcription of genes involved in differentiation of HSCs | 7.322618e-08 | 7.135 |
R-HSA-2565942 | Regulation of PLK1 Activity at G2/M Transition | 7.322618e-08 | 7.135 |
R-HSA-5687128 | MAPK6/MAPK4 signaling | 7.644696e-08 | 7.117 |
R-HSA-9909615 | Regulation of PD-L1(CD274) Post-translational modification | 7.977249e-08 | 7.098 |
R-HSA-69620 | Cell Cycle Checkpoints | 8.222537e-08 | 7.085 |
R-HSA-6804756 | Regulation of TP53 Activity through Phosphorylation | 8.320502e-08 | 7.080 |
R-HSA-70268 | Pyruvate metabolism | 8.674678e-08 | 7.062 |
R-HSA-9663891 | Selective autophagy | 9.040006e-08 | 7.044 |
R-HSA-1236974 | ER-Phagosome pathway | 9.416714e-08 | 7.026 |
R-HSA-202424 | Downstream TCR signaling | 9.805036e-08 | 7.009 |
R-HSA-9772573 | Late SARS-CoV-2 Infection Events | 1.104203e-07 | 6.957 |
R-HSA-174824 | Plasma lipoprotein assembly, remodeling, and clearance | 1.104203e-07 | 6.957 |
R-HSA-68867 | Assembly of the pre-replicative complex | 1.147917e-07 | 6.940 |
R-HSA-168928 | DDX58/IFIH1-mediated induction of interferon-alpha/beta | 1.239212e-07 | 6.907 |
R-HSA-9954709 | Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | 1.286841e-07 | 6.890 |
R-HSA-5607764 | CLEC7A (Dectin-1) signaling | 1.335826e-07 | 6.874 |
R-HSA-170834 | Signaling by TGF-beta Receptor Complex | 1.386191e-07 | 6.858 |
R-HSA-8878159 | Transcriptional regulation by RUNX3 | 1.386191e-07 | 6.858 |
R-HSA-975871 | MyD88 cascade initiated on plasma membrane | 1.437962e-07 | 6.842 |
R-HSA-168142 | Toll Like Receptor 10 (TLR10) Cascade | 1.437962e-07 | 6.842 |
R-HSA-168176 | Toll Like Receptor 5 (TLR5) Cascade | 1.437962e-07 | 6.842 |
R-HSA-190236 | Signaling by FGFR | 1.437962e-07 | 6.842 |
R-HSA-193704 | p75 NTR receptor-mediated signalling | 1.491164e-07 | 6.826 |
R-HSA-382556 | ABC-family proteins mediated transport | 1.545824e-07 | 6.811 |
R-HSA-5610787 | Hedgehog 'off' state | 1.545824e-07 | 6.811 |
R-HSA-9020702 | Interleukin-1 signaling | 1.601966e-07 | 6.795 |
R-HSA-2559580 | Oxidative Stress Induced Senescence | 1.659619e-07 | 6.780 |
R-HSA-8856825 | Cargo recognition for clathrin-mediated endocytosis | 1.779559e-07 | 6.750 |
R-HSA-9833110 | RSV-host interactions | 1.841901e-07 | 6.735 |
R-HSA-5696398 | Nucleotide Excision Repair | 1.905860e-07 | 6.720 |
R-HSA-168164 | Toll Like Receptor 3 (TLR3) Cascade | 1.905860e-07 | 6.720 |
R-HSA-69239 | Synthesis of DNA | 2.038741e-07 | 6.691 |
R-HSA-9725370 | Signaling by ALK fusions and activated point mutants | 2.038741e-07 | 6.691 |
R-HSA-9700206 | Signaling by ALK in cancer | 2.038741e-07 | 6.691 |
R-HSA-975138 | TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | 2.107717e-07 | 6.676 |
R-HSA-1236975 | Antigen processing-Cross presentation | 2.107717e-07 | 6.676 |
R-HSA-2672351 | Stimuli-sensing channels | 2.107717e-07 | 6.676 |
R-HSA-975155 | MyD88 dependent cascade initiated on endosome | 2.178422e-07 | 6.662 |
R-HSA-69002 | DNA Replication Pre-Initiation | 2.178422e-07 | 6.662 |
R-HSA-937061 | TRIF (TICAM1)-mediated TLR4 signaling | 2.250884e-07 | 6.648 |
R-HSA-166166 | MyD88-independent TLR4 cascade | 2.250884e-07 | 6.648 |
R-HSA-202403 | TCR signaling | 2.250884e-07 | 6.648 |
R-HSA-168181 | Toll Like Receptor 7/8 (TLR7/8) Cascade | 2.479098e-07 | 6.606 |
R-HSA-5693567 | HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 2.558874e-07 | 6.592 |
R-HSA-168138 | Toll Like Receptor 9 (TLR9) Cascade | 2.724163e-07 | 6.565 |
R-HSA-909733 | Interferon alpha/beta signaling | 2.809734e-07 | 6.551 |
R-HSA-5693538 | Homology Directed Repair | 3.078519e-07 | 6.512 |
R-HSA-166058 | MyD88:MAL(TIRAP) cascade initiated on plasma membrane | 3.172238e-07 | 6.499 |
R-HSA-168188 | Toll Like Receptor TLR6:TLR2 Cascade | 3.172238e-07 | 6.499 |
R-HSA-8878166 | Transcriptional regulation by RUNX2 | 3.172238e-07 | 6.499 |
R-HSA-9694516 | SARS-CoV-2 Infection | 3.339487e-07 | 6.476 |
R-HSA-9635486 | Infection with Mycobacterium tuberculosis | 3.366051e-07 | 6.473 |
R-HSA-9759194 | Nuclear events mediated by NFE2L2 | 3.366051e-07 | 6.473 |
R-HSA-168179 | Toll Like Receptor TLR1:TLR2 Cascade | 3.466207e-07 | 6.460 |
R-HSA-181438 | Toll Like Receptor 2 (TLR2) Cascade | 3.466207e-07 | 6.460 |
R-HSA-162909 | Host Interactions of HIV factors | 3.673174e-07 | 6.435 |
R-HSA-69206 | G1/S Transition | 3.889230e-07 | 6.410 |
R-HSA-69481 | G2/M Checkpoints | 4.114634e-07 | 6.386 |
R-HSA-9909396 | Circadian clock | 4.849574e-07 | 6.314 |
R-HSA-68886 | M Phase | 5.161035e-07 | 6.287 |
R-HSA-3858494 | Beta-catenin independent WNT signaling | 5.533350e-07 | 6.257 |
R-HSA-9820952 | Respiratory Syncytial Virus Infection Pathway | 5.678301e-07 | 6.246 |
R-HSA-5358351 | Signaling by Hedgehog | 5.826066e-07 | 6.235 |
R-HSA-6807070 | PTEN Regulation | 5.976682e-07 | 6.224 |
R-HSA-1632852 | Macroautophagy | 6.286607e-07 | 6.202 |
R-HSA-162599 | Late Phase of HIV Life Cycle | 6.608366e-07 | 6.180 |
R-HSA-9705671 | SARS-CoV-2 activates/modulates innate and adaptive immune responses | 6.608366e-07 | 6.180 |
R-HSA-8856828 | Clathrin-mediated endocytosis | 6.773775e-07 | 6.169 |
R-HSA-2871837 | FCERI mediated NF-kB activation | 6.942252e-07 | 6.158 |
R-HSA-453279 | Mitotic G1 phase and G1/S transition | 7.288562e-07 | 6.137 |
R-HSA-166016 | Toll Like Receptor 4 (TLR4) Cascade | 7.647597e-07 | 6.116 |
R-HSA-69242 | S Phase | 7.647597e-07 | 6.116 |
R-HSA-9755511 | KEAP1-NFE2L2 pathway | 8.210671e-07 | 6.086 |
R-HSA-446652 | Interleukin-1 family signaling | 8.405055e-07 | 6.075 |
R-HSA-9609507 | Protein localization | 8.602851e-07 | 6.065 |
R-HSA-69306 | DNA Replication | 8.602851e-07 | 6.065 |
R-HSA-5693532 | DNA Double-Strand Break Repair | 8.602851e-07 | 6.065 |
R-HSA-73887 | Death Receptor Signaling | 8.804096e-07 | 6.055 |
R-HSA-1169410 | Antiviral mechanism by IFN-stimulated genes | 8.804096e-07 | 6.055 |
R-HSA-72766 | Translation | 8.892788e-07 | 6.051 |
R-HSA-9612973 | Autophagy | 9.217095e-07 | 6.035 |
R-HSA-162587 | HIV Life Cycle | 9.428928e-07 | 6.026 |
R-HSA-983705 | Signaling by the B Cell Receptor (BCR) | 9.644369e-07 | 6.016 |
R-HSA-9006936 | Signaling by TGFB family members | 1.008624e-06 | 5.996 |
R-HSA-5633007 | Regulation of TP53 Activity | 1.008624e-06 | 5.996 |
R-HSA-109581 | Apoptosis | 1.054303e-06 | 5.977 |
R-HSA-5621481 | C-type lectin receptors (CLRs) | 1.306230e-06 | 5.884 |
R-HSA-9909648 | Regulation of PD-L1(CD274) expression | 1.333680e-06 | 5.875 |
R-HSA-5689880 | Ub-specific processing proteases | 1.361558e-06 | 5.866 |
R-HSA-9764274 | Regulation of Expression and Function of Type I Classical Cadherins | 1.361558e-06 | 5.866 |
R-HSA-9764265 | Regulation of CDH1 Expression and Function | 1.361558e-06 | 5.866 |
R-HSA-2559583 | Cellular Senescence | 1.569041e-06 | 5.804 |
R-HSA-201681 | TCF dependent signaling in response to WNT | 1.664816e-06 | 5.779 |
R-HSA-69275 | G2/M Transition | 1.764879e-06 | 5.753 |
R-HSA-2262752 | Cellular responses to stress | 1.803122e-06 | 5.744 |
R-HSA-453274 | Mitotic G2-G2/M phases | 1.834031e-06 | 5.737 |
R-HSA-983712 | Ion channel transport | 1.869354e-06 | 5.728 |
R-HSA-168898 | Toll-like Receptor Cascades | 1.941517e-06 | 5.712 |
R-HSA-9759476 | Regulation of Homotypic Cell-Cell Adhesion | 2.130995e-06 | 5.671 |
R-HSA-389948 | Co-inhibition by PD-1 | 2.292221e-06 | 5.640 |
R-HSA-2454202 | Fc epsilon receptor (FCERI) signaling | 2.418970e-06 | 5.616 |
R-HSA-5357801 | Programmed Cell Death | 2.550864e-06 | 5.593 |
R-HSA-422475 | Axon guidance | 2.748134e-06 | 5.561 |
R-HSA-9679506 | SARS-CoV Infections | 2.994847e-06 | 5.524 |
R-HSA-418990 | Adherens junctions interactions | 3.185163e-06 | 5.497 |
R-HSA-69278 | Cell Cycle, Mitotic | 3.286165e-06 | 5.483 |
R-HSA-8951664 | Neddylation | 3.346805e-06 | 5.475 |
R-HSA-8953897 | Cellular responses to stimuli | 3.550536e-06 | 5.450 |
R-HSA-8878171 | Transcriptional regulation by RUNX1 | 3.629665e-06 | 5.440 |
R-HSA-162906 | HIV Infection | 3.688304e-06 | 5.433 |
R-HSA-9675108 | Nervous system development | 3.749510e-06 | 5.426 |
R-HSA-157118 | Signaling by NOTCH | 4.516457e-06 | 5.345 |
R-HSA-5619115 | Disorders of transmembrane transporters | 5.015779e-06 | 5.300 |
R-HSA-421270 | Cell-cell junction organization | 5.318893e-06 | 5.274 |
R-HSA-5688426 | Deubiquitination | 5.635410e-06 | 5.249 |
R-HSA-388841 | Regulation of T cell activation by CD28 family | 5.716678e-06 | 5.243 |
R-HSA-9711123 | Cellular response to chemical stress | 6.761279e-06 | 5.170 |
R-HSA-446728 | Cell junction organization | 7.734813e-06 | 5.112 |
R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation | 8.151974e-06 | 5.089 |
R-HSA-5673001 | RAF/MAP kinase cascade | 8.921887e-06 | 5.050 |
R-HSA-1640170 | Cell Cycle | 9.489547e-06 | 5.023 |
R-HSA-1257604 | PIP3 activates AKT signaling | 9.623656e-06 | 5.017 |
R-HSA-5684996 | MAPK1/MAPK3 signaling | 9.744481e-06 | 5.011 |
R-HSA-195721 | Signaling by WNT | 9.989502e-06 | 5.000 |
R-HSA-156902 | Peptide chain elongation | 1.196620e-05 | 4.922 |
R-HSA-1500931 | Cell-Cell communication | 1.240557e-05 | 4.906 |
R-HSA-9954714 | PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | 1.310197e-05 | 4.883 |
R-HSA-975956 | Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 1.349582e-05 | 4.870 |
R-HSA-156842 | Eukaryotic Translation Elongation | 1.389742e-05 | 4.857 |
R-HSA-72689 | Formation of a pool of free 40S subunits | 1.558279e-05 | 4.807 |
R-HSA-72764 | Eukaryotic Translation Termination | 1.558279e-05 | 4.807 |
R-HSA-1428517 | Aerobic respiration and respiratory electron transport | 1.644742e-05 | 4.784 |
R-HSA-9006925 | Intracellular signaling by second messengers | 1.662706e-05 | 4.779 |
R-HSA-5683057 | MAPK family signaling cascades | 1.754717e-05 | 4.756 |
R-HSA-2408557 | Selenocysteine synthesis | 1.835578e-05 | 4.736 |
R-HSA-192823 | Viral mRNA Translation | 1.934774e-05 | 4.713 |
R-HSA-9633012 | Response of EIF2AK4 (GCN2) to amino acid deficiency | 1.985672e-05 | 4.702 |
R-HSA-73894 | DNA Repair | 2.011578e-05 | 4.696 |
R-HSA-8953854 | Metabolism of RNA | 2.075250e-05 | 4.683 |
R-HSA-1799339 | SRP-dependent cotranslational protein targeting to membrane | 2.198107e-05 | 4.658 |
R-HSA-72706 | GTP hydrolysis and joining of the 60S ribosomal subunit | 2.253461e-05 | 4.647 |
R-HSA-156827 | L13a-mediated translational silencing of Ceruloplasmin expression | 2.253461e-05 | 4.647 |
R-HSA-927802 | Nonsense-Mediated Decay (NMD) | 2.484078e-05 | 4.605 |
R-HSA-975957 | Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 2.484078e-05 | 4.605 |
R-HSA-983169 | Class I MHC mediated antigen processing & presentation | 2.557530e-05 | 4.592 |
R-HSA-913531 | Interferon Signaling | 2.557530e-05 | 4.592 |
R-HSA-9824439 | Bacterial Infection Pathways | 2.735569e-05 | 4.563 |
R-HSA-72613 | Eukaryotic Translation Initiation | 2.858385e-05 | 4.544 |
R-HSA-72737 | Cap-dependent Translation Initiation | 2.858385e-05 | 4.544 |
R-HSA-446203 | Asparagine N-linked glycosylation | 3.668441e-05 | 4.436 |
R-HSA-5668914 | Diseases of metabolism | 3.832999e-05 | 4.416 |
R-HSA-71387 | Metabolism of carbohydrates and carbohydrate derivatives | 4.857230e-05 | 4.314 |
R-HSA-3700989 | Transcriptional Regulation by TP53 | 5.267743e-05 | 4.278 |
R-HSA-168273 | Influenza Viral RNA Transcription and Replication | 6.668952e-05 | 4.176 |
R-HSA-9711097 | Cellular response to starvation | 7.017009e-05 | 4.154 |
R-HSA-5663202 | Diseases of signal transduction by growth factor receptors and second messengers | 7.714823e-05 | 4.113 |
R-HSA-2408522 | Selenoamino acid metabolism | 7.748501e-05 | 4.111 |
R-HSA-9824446 | Viral Infection Pathways | 8.584495e-05 | 4.066 |
R-HSA-6791226 | Major pathway of rRNA processing in the nucleolus and cytosol | 8.663163e-05 | 4.062 |
R-HSA-168255 | Influenza Infection | 9.939634e-05 | 4.003 |
R-HSA-8868773 | rRNA processing in the nucleus and cytosol | 1.133364e-04 | 3.946 |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | 1.480290e-04 | 3.830 |
R-HSA-449147 | Signaling by Interleukins | 1.591676e-04 | 3.798 |
R-HSA-9735869 | SARS-CoV-1 modulates host translation machinery | 1.796750e-04 | 3.746 |
R-HSA-199991 | Membrane Trafficking | 1.822158e-04 | 3.739 |
R-HSA-72312 | rRNA processing | 2.023359e-04 | 3.694 |
R-HSA-72695 | Formation of the ternary complex, and subsequently, the 43S complex | 3.106734e-04 | 3.508 |
R-HSA-72649 | Translation initiation complex formation | 4.087296e-04 | 3.389 |
R-HSA-9754678 | SARS-CoV-2 modulates host translation machinery | 4.087296e-04 | 3.389 |
R-HSA-5653656 | Vesicle-mediated transport | 4.157479e-04 | 3.381 |
R-HSA-72702 | Ribosomal scanning and start codon recognition | 4.353081e-04 | 3.361 |
R-HSA-72662 | Activation of the mRNA upon binding of the cap-binding complex and eIFs, and sub... | 4.627098e-04 | 3.335 |
R-HSA-5663205 | Infectious disease | 5.763139e-04 | 3.239 |
R-HSA-382551 | Transport of small molecules | 8.561293e-04 | 3.067 |
R-HSA-1280218 | Adaptive Immune System | 1.086063e-03 | 2.964 |
R-HSA-1266738 | Developmental Biology | 1.107430e-03 | 2.956 |
R-HSA-1280215 | Cytokine Signaling in Immune system | 1.197622e-03 | 2.922 |
R-HSA-168249 | Innate Immune System | 2.622841e-03 | 2.581 |
R-HSA-392499 | Metabolism of proteins | 2.933356e-03 | 2.533 |
R-HSA-71291 | Metabolism of amino acids and derivatives | 3.010488e-03 | 2.521 |
R-HSA-212436 | Generic Transcription Pathway | 4.611282e-03 | 2.336 |
R-HSA-597592 | Post-translational protein modification | 5.864350e-03 | 2.232 |
R-HSA-1643685 | Disease | 6.079085e-03 | 2.216 |
R-HSA-73857 | RNA Polymerase II Transcription | 6.320954e-03 | 2.199 |
R-HSA-162582 | Signal Transduction | 8.166367e-03 | 2.088 |
R-HSA-74160 | Gene expression (Transcription) | 1.079869e-02 | 1.967 |
R-HSA-1430728 | Metabolism | 2.050412e-02 | 1.688 |
R-HSA-3371511 | HSF1 activation | 2.116389e-02 | 1.674 |
R-HSA-3371568 | Attenuation phase | 2.311255e-02 | 1.636 |
R-HSA-3371571 | HSF1-dependent transactivation | 2.893817e-02 | 1.539 |
R-HSA-168256 | Immune System | 3.508596e-02 | 1.455 |
R-HSA-141444 | Amplification of signal from unattached kinetochores via a MAD2 inhibitory si... | 4.575632e-02 | 1.340 |
R-HSA-141424 | Amplification of signal from the kinetochores | 4.575632e-02 | 1.340 |
R-HSA-69618 | Mitotic Spindle Checkpoint | 5.383276e-02 | 1.269 |
R-HSA-3371453 | Regulation of HSF1-mediated heat shock response | 5.477899e-02 | 1.261 |
R-HSA-9648025 | EML4 and NUDC in mitotic spindle formation | 5.855562e-02 | 1.232 |
R-HSA-2500257 | Resolution of Sister Chromatid Cohesion | 6.513296e-02 | 1.186 |
R-HSA-3371556 | Cellular response to heat stress | 6.513296e-02 | 1.186 |
R-HSA-68877 | Mitotic Prometaphase | 1.005946e-01 | 0.997 |
Download
kinase | JSD_mean | pearson_surrounding | kinase_max_IC_position | max_position_JSD |
---|---|---|---|---|
TGFBR2 |
0.517 | 0.226 | -2 | 0.608 |
DSTYK |
0.512 | 0.134 | 2 | 0.299 |
NEK6 |
0.512 | 0.187 | -2 | 0.529 |
IKKE |
0.506 | 0.078 | 1 | 0.563 |
NEK7 |
0.506 | 0.135 | -3 | 0.533 |
ACVR2A |
0.501 | 0.193 | -2 | 0.607 |
IKKB |
0.501 | -0.001 | -2 | 0.240 |
BMPR2 |
0.500 | 0.210 | -2 | 0.434 |
BMPR1B |
0.500 | 0.084 | 1 | 0.354 |
FAM20C |
0.500 | 0.048 | 2 | 0.336 |
COT |
0.499 | 0.055 | 2 | 0.266 |
TBK1 |
0.499 | 0.032 | 1 | 0.552 |
ACVR2B |
0.499 | 0.175 | -2 | 0.587 |
TGFBR1 |
0.497 | 0.057 | -2 | 0.458 |
IKKA |
0.497 | 0.003 | -2 | 0.263 |
PLK1 |
0.497 | 0.161 | -2 | 0.603 |
ULK2 |
0.497 | 0.012 | 2 | 0.201 |
CDK3 |
0.494 | 0.123 | 1 | 0.313 |
KIS |
0.494 | 0.066 | 1 | 0.411 |
PERK |
0.494 | 0.191 | -2 | 0.538 |
CDC7 |
0.491 | 0.013 | 1 | 0.404 |
ALK4 |
0.491 | 0.064 | -2 | 0.451 |
PDHK1 |
0.491 | -0.052 | 1 | 0.557 |
GCN2 |
0.491 | 0.038 | 2 | 0.216 |
CLK3 |
0.491 | 0.064 | 1 | 0.434 |
PLK4 |
0.490 | 0.057 | 2 | 0.145 |
ALK2 |
0.490 | 0.058 | -2 | 0.473 |
MARK4 |
0.490 | -0.037 | 4 | 0.537 |
PLK3 |
0.489 | 0.054 | 2 | 0.260 |
CHAK2 |
0.489 | 0.067 | -1 | 0.318 |
BMPR1A |
0.488 | 0.068 | 1 | 0.340 |
HRI |
0.488 | 0.165 | -2 | 0.536 |
ERK5 |
0.488 | -0.034 | 1 | 0.517 |
PRPK |
0.488 | -0.111 | -1 | 0.393 |
PIM3 |
0.488 | -0.001 | -3 | 0.356 |
NLK |
0.487 | -0.023 | 1 | 0.478 |
TLK2 |
0.487 | 0.066 | 1 | 0.429 |
MOS |
0.487 | -0.009 | 1 | 0.463 |
CDK1 |
0.485 | 0.059 | 1 | 0.319 |
GRK1 |
0.485 | -0.038 | -2 | 0.282 |
RAF1 |
0.485 | -0.052 | 1 | 0.525 |
PRKD1 |
0.484 | -0.023 | -3 | 0.384 |
MTOR |
0.484 | -0.072 | 1 | 0.462 |
CDK2 |
0.484 | 0.114 | 1 | 0.364 |
SRPK1 |
0.484 | 0.007 | -3 | 0.329 |
CAMK2G |
0.484 | -0.086 | 2 | 0.281 |
NEK9 |
0.484 | -0.039 | 2 | 0.224 |
GRK7 |
0.484 | 0.065 | 1 | 0.349 |
PDHK4 |
0.483 | -0.166 | 1 | 0.509 |
MLK1 |
0.482 | -0.038 | 2 | 0.212 |
ATR |
0.482 | -0.068 | 1 | 0.413 |
GRK4 |
0.482 | -0.019 | -2 | 0.417 |
ULK1 |
0.482 | -0.050 | -3 | 0.515 |
MPSK1 |
0.481 | 0.079 | 1 | 0.565 |
ANKRD3 |
0.481 | 0.002 | 1 | 0.512 |
MARK2 |
0.481 | -0.030 | 4 | 0.557 |
TTBK2 |
0.480 | -0.045 | 2 | 0.173 |
TSSK1 |
0.480 | -0.050 | -3 | 0.409 |
SMG1 |
0.479 | -0.045 | 1 | 0.397 |
HIPK4 |
0.479 | -0.012 | 1 | 0.401 |
SRPK3 |
0.478 | 0.025 | -3 | 0.319 |
YSK4 |
0.478 | -0.013 | 1 | 0.501 |
TSSK2 |
0.478 | -0.072 | -5 | 0.540 |
P38D |
0.478 | -0.001 | 1 | 0.348 |
CDK5 |
0.477 | 0.019 | 1 | 0.389 |
QSK |
0.477 | -0.039 | 4 | 0.533 |
GRK5 |
0.476 | -0.091 | -3 | 0.481 |
MARK3 |
0.476 | -0.040 | 4 | 0.522 |
MASTL |
0.475 | -0.158 | -2 | 0.314 |
PKR |
0.475 | 0.007 | 1 | 0.490 |
BCKDK |
0.475 | -0.109 | -1 | 0.299 |
MLK3 |
0.475 | -0.020 | 2 | 0.185 |
PINK1 |
0.475 | -0.013 | 1 | 0.486 |
P38B |
0.475 | -0.023 | 1 | 0.389 |
SKMLCK |
0.475 | -0.091 | -2 | 0.267 |
MEK1 |
0.474 | -0.065 | 2 | 0.282 |
MST4 |
0.474 | -0.025 | 2 | 0.283 |
NEK2 |
0.474 | -0.064 | 2 | 0.237 |
CAMLCK |
0.473 | -0.087 | -2 | 0.278 |
CDKL5 |
0.473 | -0.046 | -3 | 0.394 |
PIM1 |
0.473 | -0.025 | -3 | 0.295 |
ATM |
0.473 | -0.045 | 1 | 0.344 |
MLK2 |
0.473 | -0.089 | 2 | 0.243 |
HUNK |
0.472 | -0.152 | 2 | 0.236 |
VRK2 |
0.472 | -0.082 | 1 | 0.501 |
CDK8 |
0.472 | -0.048 | 1 | 0.389 |
SRPK2 |
0.472 | 0.007 | -3 | 0.262 |
PLK2 |
0.472 | 0.015 | -3 | 0.346 |
TTBK1 |
0.472 | -0.043 | 2 | 0.142 |
CDKL1 |
0.471 | -0.067 | -3 | 0.396 |
CAMK2D |
0.471 | -0.125 | -3 | 0.427 |
TLK1 |
0.471 | 0.038 | -2 | 0.527 |
CAMK1B |
0.471 | -0.128 | -3 | 0.428 |
PRKD2 |
0.470 | -0.039 | -3 | 0.322 |
DAPK2 |
0.470 | -0.095 | -3 | 0.449 |
WNK3 |
0.470 | -0.131 | 1 | 0.493 |
AMPKA1 |
0.470 | -0.080 | -3 | 0.391 |
PRP4 |
0.470 | -0.019 | -3 | 0.411 |
DNAPK |
0.469 | -0.053 | 1 | 0.416 |
MLK4 |
0.469 | -0.029 | 2 | 0.160 |
NIK |
0.469 | -0.148 | -3 | 0.440 |
WNK1 |
0.469 | -0.122 | -2 | 0.240 |
CHAK1 |
0.468 | -0.018 | 2 | 0.279 |
JNK2 |
0.468 | -0.028 | 1 | 0.355 |
NIM1 |
0.468 | -0.097 | 3 | 0.432 |
RIPK3 |
0.468 | -0.137 | 3 | 0.396 |
NEK5 |
0.468 | -0.032 | 1 | 0.501 |
JNK3 |
0.468 | -0.035 | 1 | 0.365 |
BIKE |
0.468 | 0.148 | 1 | 0.665 |
LATS1 |
0.468 | -0.011 | -3 | 0.377 |
NUAK2 |
0.467 | -0.088 | -3 | 0.387 |
AAK1 |
0.467 | 0.161 | 1 | 0.658 |
IRE1 |
0.466 | -0.082 | 1 | 0.445 |
PKCD |
0.466 | -0.070 | 2 | 0.201 |
ICK |
0.466 | -0.077 | -3 | 0.414 |
IRE2 |
0.466 | -0.061 | 2 | 0.163 |
AURC |
0.466 | -0.037 | -2 | 0.160 |
PKN3 |
0.466 | -0.118 | -3 | 0.407 |
MARK1 |
0.465 | -0.074 | 4 | 0.516 |
CDK7 |
0.465 | -0.035 | 1 | 0.385 |
GRK6 |
0.464 | -0.126 | 1 | 0.411 |
ERK1 |
0.464 | -0.043 | 1 | 0.392 |
CLK1 |
0.464 | -0.020 | -3 | 0.307 |
CDK19 |
0.464 | -0.053 | 1 | 0.377 |
GAK |
0.464 | 0.073 | 1 | 0.612 |
CDK13 |
0.464 | -0.049 | 1 | 0.370 |
MEKK1 |
0.464 | -0.072 | 1 | 0.514 |
CAMKK1 |
0.463 | -0.051 | -2 | 0.238 |
PAK6 |
0.463 | -0.068 | -2 | 0.150 |
PBK |
0.463 | 0.099 | 1 | 0.670 |
P38A |
0.463 | -0.054 | 1 | 0.432 |
CLK4 |
0.463 | -0.035 | -3 | 0.308 |
SSTK |
0.463 | -0.069 | 4 | 0.532 |
TTK |
0.463 | 0.214 | -2 | 0.632 |
MEKK2 |
0.463 | -0.030 | 2 | 0.206 |
AURB |
0.462 | -0.053 | -2 | 0.167 |
DLK |
0.462 | -0.171 | 1 | 0.439 |
NDR2 |
0.462 | -0.114 | -3 | 0.364 |
RSK2 |
0.462 | -0.082 | -3 | 0.336 |
CK2A2 |
0.462 | -0.017 | 1 | 0.342 |
CAMK2B |
0.462 | -0.109 | 2 | 0.295 |
MEK2 |
0.462 | -0.022 | 2 | 0.245 |
PKG2 |
0.461 | -0.063 | -2 | 0.159 |
AMPKA2 |
0.461 | -0.091 | -3 | 0.357 |
TNIK |
0.461 | 0.073 | 3 | 0.612 |
QIK |
0.461 | -0.125 | -3 | 0.437 |
P38G |
0.461 | -0.036 | 1 | 0.298 |
RSK3 |
0.460 | -0.080 | -3 | 0.335 |
PKCA |
0.460 | -0.076 | 2 | 0.172 |
ERK7 |
0.460 | -0.034 | 2 | 0.115 |
MST2 |
0.460 | 0.005 | 1 | 0.529 |
MINK |
0.460 | 0.061 | 1 | 0.553 |
SIK |
0.460 | -0.075 | -3 | 0.312 |
HGK |
0.460 | 0.034 | 3 | 0.581 |
PRKD3 |
0.459 | -0.068 | -3 | 0.324 |
RIPK1 |
0.459 | -0.195 | 1 | 0.434 |
BRSK2 |
0.459 | -0.098 | -3 | 0.366 |
CDK6 |
0.459 | -0.005 | 1 | 0.390 |
DYRK2 |
0.459 | -0.076 | 1 | 0.382 |
IRAK1 |
0.458 | -0.131 | -1 | 0.371 |
PIM2 |
0.458 | -0.040 | -3 | 0.323 |
LATS2 |
0.458 | -0.103 | -5 | 0.400 |
ZAK |
0.458 | -0.091 | 1 | 0.460 |
AURA |
0.458 | -0.062 | -2 | 0.178 |
CLK2 |
0.457 | -0.023 | -3 | 0.268 |
CHK1 |
0.457 | -0.120 | -3 | 0.347 |
BUB1 |
0.457 | 0.019 | -5 | 0.501 |
JNK1 |
0.457 | -0.036 | 1 | 0.327 |
CDK12 |
0.457 | -0.056 | 1 | 0.351 |
PAK3 |
0.457 | -0.116 | -2 | 0.196 |
PKN2 |
0.457 | -0.130 | -3 | 0.397 |
MAPKAPK3 |
0.456 | -0.111 | -3 | 0.319 |
MEKK3 |
0.456 | -0.096 | 1 | 0.477 |
TAO3 |
0.456 | -0.013 | 1 | 0.475 |
IRAK4 |
0.456 | -0.101 | 1 | 0.473 |
P90RSK |
0.456 | -0.106 | -3 | 0.339 |
BRSK1 |
0.455 | -0.100 | -3 | 0.333 |
NDR1 |
0.455 | -0.128 | -3 | 0.358 |
NEK4 |
0.455 | -0.060 | 1 | 0.535 |
TAK1 |
0.455 | -0.017 | 1 | 0.471 |
PAK1 |
0.455 | -0.106 | -2 | 0.200 |
CAMKK2 |
0.455 | -0.070 | -2 | 0.211 |
NEK8 |
0.455 | -0.047 | 2 | 0.218 |
GSK3B |
0.455 | -0.054 | 4 | 0.130 |
LKB1 |
0.454 | -0.048 | -3 | 0.484 |
GRK2 |
0.454 | -0.093 | -2 | 0.298 |
BRAF |
0.454 | -0.117 | -4 | 0.508 |
PKACG |
0.453 | -0.108 | -2 | 0.204 |
MAPKAPK2 |
0.453 | -0.079 | -3 | 0.255 |
MST1 |
0.453 | 0.020 | 1 | 0.533 |
CDK9 |
0.453 | -0.072 | 1 | 0.382 |
PAK2 |
0.453 | -0.121 | -2 | 0.199 |
NUAK1 |
0.453 | -0.097 | -3 | 0.332 |
CAMK2A |
0.453 | -0.118 | 2 | 0.297 |
MELK |
0.453 | -0.125 | -3 | 0.355 |
MAK |
0.452 | -0.024 | -2 | 0.155 |
MEK5 |
0.452 | -0.169 | 2 | 0.242 |
GRK3 |
0.452 | -0.080 | -2 | 0.295 |
PHKG1 |
0.452 | -0.105 | -3 | 0.342 |
PKCZ |
0.452 | -0.104 | 2 | 0.201 |
EEF2K |
0.451 | 0.000 | 3 | 0.632 |
MNK2 |
0.451 | -0.106 | -2 | 0.219 |
CDK18 |
0.451 | -0.056 | 1 | 0.347 |
PKCB |
0.451 | -0.095 | 2 | 0.171 |
CK2A1 |
0.451 | -0.040 | 1 | 0.320 |
CK1G1 |
0.450 | -0.062 | -3 | 0.173 |
WNK4 |
0.450 | -0.146 | -2 | 0.259 |
P70S6KB |
0.450 | -0.114 | -3 | 0.351 |
ERK2 |
0.450 | -0.074 | 1 | 0.375 |
GSK3A |
0.450 | -0.055 | 4 | 0.134 |
GCK |
0.449 | -0.003 | 1 | 0.523 |
NEK1 |
0.449 | -0.079 | 1 | 0.494 |
MST3 |
0.449 | -0.085 | 2 | 0.263 |
PKACB |
0.448 | -0.072 | -2 | 0.185 |
CDK17 |
0.448 | -0.057 | 1 | 0.296 |
TAO2 |
0.448 | -0.068 | 2 | 0.256 |
CK1D |
0.448 | -0.067 | -3 | 0.170 |
PKCG |
0.448 | -0.118 | 2 | 0.174 |
KHS1 |
0.448 | 0.006 | 1 | 0.566 |
PKCH |
0.447 | -0.121 | 2 | 0.149 |
LOK |
0.447 | -0.042 | -2 | 0.242 |
DYRK1A |
0.447 | -0.075 | 1 | 0.400 |
NEK3 |
0.447 | -0.089 | 1 | 0.504 |
DYRK4 |
0.447 | -0.073 | 1 | 0.343 |
HIPK3 |
0.446 | -0.080 | 1 | 0.429 |
MYLK4 |
0.446 | -0.120 | -2 | 0.213 |
PDK1 |
0.446 | -0.110 | 1 | 0.459 |
KHS2 |
0.446 | 0.017 | 1 | 0.554 |
SGK3 |
0.446 | -0.111 | -3 | 0.337 |
MSK1 |
0.446 | -0.110 | -3 | 0.310 |
STK33 |
0.445 | -0.096 | 2 | 0.155 |
HIPK1 |
0.445 | -0.069 | 1 | 0.408 |
VRK1 |
0.445 | -0.097 | 2 | 0.224 |
HIPK2 |
0.445 | -0.049 | 1 | 0.330 |
OSR1 |
0.444 | 0.014 | 2 | 0.225 |
DCAMKL1 |
0.444 | -0.118 | -3 | 0.298 |
NEK11 |
0.443 | -0.134 | 1 | 0.480 |
AKT2 |
0.443 | -0.076 | -3 | 0.275 |
DYRK1B |
0.443 | -0.064 | 1 | 0.372 |
SNRK |
0.443 | -0.180 | 2 | 0.165 |
HPK1 |
0.442 | -0.040 | 1 | 0.534 |
RIPK2 |
0.442 | -0.146 | 1 | 0.459 |
RSK4 |
0.441 | -0.105 | -3 | 0.297 |
CAMK4 |
0.441 | -0.188 | -3 | 0.359 |
CDK4 |
0.441 | -0.051 | 1 | 0.346 |
MSK2 |
0.441 | -0.132 | -3 | 0.305 |
MEKK6 |
0.441 | -0.128 | 1 | 0.496 |
PAK4 |
0.441 | -0.089 | -2 | 0.151 |
DRAK1 |
0.441 | -0.162 | 1 | 0.300 |
PKACA |
0.441 | -0.078 | -2 | 0.149 |
MAPKAPK5 |
0.441 | -0.133 | -3 | 0.319 |
PAK5 |
0.440 | -0.097 | -2 | 0.142 |
PKCT |
0.440 | -0.119 | 2 | 0.152 |
DCAMKL2 |
0.440 | -0.122 | -3 | 0.336 |
MNK1 |
0.440 | -0.122 | -2 | 0.226 |
PKCI |
0.440 | -0.102 | 2 | 0.174 |
SLK |
0.439 | -0.050 | -2 | 0.239 |
PRKX |
0.439 | -0.062 | -3 | 0.224 |
MYO3B |
0.439 | -0.015 | 2 | 0.262 |
SMMLCK |
0.437 | -0.134 | -3 | 0.408 |
MAP3K15 |
0.437 | -0.138 | 1 | 0.465 |
CDK14 |
0.437 | -0.083 | 1 | 0.386 |
MYO3A |
0.437 | 0.009 | 1 | 0.507 |
PKCE |
0.436 | -0.081 | 2 | 0.171 |
DYRK3 |
0.436 | -0.095 | 1 | 0.409 |
YSK1 |
0.436 | -0.097 | 2 | 0.215 |
PASK |
0.436 | -0.141 | -3 | 0.413 |
CK1E |
0.435 | -0.107 | -3 | 0.191 |
PKG1 |
0.434 | -0.084 | -2 | 0.115 |
LRRK2 |
0.434 | -0.148 | 2 | 0.254 |
CDK16 |
0.434 | -0.070 | 1 | 0.310 |
PHKG2 |
0.434 | -0.122 | -3 | 0.360 |
CK1A2 |
0.434 | -0.092 | -3 | 0.160 |
AKT1 |
0.433 | -0.091 | -3 | 0.280 |
YANK3 |
0.433 | -0.069 | 2 | 0.117 |
DAPK3 |
0.432 | -0.104 | -3 | 0.327 |
P70S6K |
0.432 | -0.109 | -3 | 0.313 |
MRCKB |
0.431 | -0.089 | -3 | 0.311 |
MOK |
0.431 | -0.071 | 1 | 0.424 |
AKT3 |
0.430 | -0.071 | -3 | 0.219 |
CDK10 |
0.430 | -0.071 | 1 | 0.370 |
ROCK2 |
0.429 | -0.093 | -3 | 0.319 |
TAO1 |
0.429 | -0.055 | 1 | 0.477 |
CAMK1G |
0.429 | -0.152 | -3 | 0.337 |
MRCKA |
0.428 | -0.087 | -3 | 0.298 |
CAMK1D |
0.428 | -0.127 | -3 | 0.237 |
CHK2 |
0.427 | -0.090 | -3 | 0.224 |
PKN1 |
0.427 | -0.119 | -3 | 0.323 |
SGK1 |
0.426 | -0.081 | -3 | 0.205 |
STLK3 |
0.424 | -0.081 | 1 | 0.454 |
SBK |
0.423 | -0.092 | -3 | 0.186 |
ASK1 |
0.422 | -0.138 | 1 | 0.453 |
LCK |
0.422 | 0.187 | -1 | 0.543 |
BLK |
0.421 | 0.174 | -1 | 0.532 |
DAPK1 |
0.421 | -0.129 | -3 | 0.331 |
CK1G3 |
0.418 | -0.064 | -3 | 0.082 |
HCK |
0.418 | 0.144 | -1 | 0.542 |
CAMK1A |
0.417 | -0.123 | -3 | 0.231 |
CK1A |
0.416 | -0.083 | -3 | 0.103 |
DMPK1 |
0.416 | -0.095 | -3 | 0.308 |
TXK |
0.416 | 0.118 | 1 | 0.440 |
HASPIN |
0.415 | -0.086 | -1 | 0.231 |
ALPHAK3 |
0.415 | -0.052 | -1 | 0.288 |
FYN |
0.413 | 0.118 | -1 | 0.544 |
ROCK1 |
0.413 | -0.109 | -3 | 0.295 |
YES1 |
0.412 | 0.124 | -1 | 0.592 |
LYN |
0.411 | 0.104 | 3 | 0.372 |
SRC |
0.410 | 0.116 | -1 | 0.596 |
BTK |
0.408 | 0.064 | -1 | 0.532 |
CRIK |
0.408 | -0.097 | -3 | 0.294 |
FGR |
0.406 | 0.074 | 1 | 0.533 |
TEC |
0.406 | 0.072 | -1 | 0.567 |
YANK2 |
0.405 | -0.087 | 2 | 0.120 |
PTK6 |
0.405 | 0.049 | -1 | 0.492 |
JAK1 |
0.405 | 0.083 | 1 | 0.493 |
ITK |
0.404 | 0.055 | -1 | 0.488 |
PDHK3_TYR |
0.404 | 0.017 | 4 | 0.439 |
SRMS |
0.404 | 0.030 | 1 | 0.444 |
ABL2 |
0.403 | 0.050 | -1 | 0.474 |
ABL1 |
0.402 | 0.048 | -1 | 0.513 |
FER |
0.401 | -0.003 | 1 | 0.473 |
JAK2 |
0.400 | 0.012 | 1 | 0.496 |
PTK2B |
0.400 | 0.058 | -1 | 0.621 |
MAP2K4_TYR |
0.399 | -0.013 | -1 | 0.369 |
BMX |
0.399 | 0.018 | -1 | 0.452 |
EPHB2 |
0.399 | 0.017 | -1 | 0.440 |
TYK2 |
0.399 | -0.002 | 1 | 0.500 |
EPHA6 |
0.398 | -0.005 | -1 | 0.395 |
PKMYT1_TYR |
0.397 | -0.028 | 3 | 0.494 |
TYRO3 |
0.397 | -0.018 | 3 | 0.460 |
ROS1 |
0.396 | 0.003 | 3 | 0.426 |
EPHB3 |
0.396 | -0.027 | -1 | 0.436 |
EPHB4 |
0.395 | -0.030 | -1 | 0.417 |
TNK2 |
0.395 | 0.001 | 3 | 0.376 |
CK1G2 |
0.394 | -0.091 | -3 | 0.129 |
MERTK |
0.394 | -0.020 | 3 | 0.361 |
EPHA4 |
0.393 | -0.032 | 2 | 0.289 |
TNNI3K_TYR |
0.393 | -0.008 | 1 | 0.533 |
EPHB1 |
0.393 | -0.032 | 1 | 0.454 |
CSF1R |
0.393 | -0.016 | 3 | 0.414 |
FRK |
0.392 | 0.012 | -1 | 0.528 |
MAP2K6_TYR |
0.392 | -0.069 | -1 | 0.328 |
PDHK1_TYR |
0.391 | -0.069 | -1 | 0.374 |
MAP2K7_TYR |
0.391 | -0.195 | 2 | 0.288 |
TESK1_TYR |
0.391 | -0.106 | 3 | 0.543 |
RET |
0.391 | -0.071 | 1 | 0.472 |
BMPR2_TYR |
0.390 | -0.063 | -1 | 0.311 |
AXL |
0.389 | -0.052 | 3 | 0.382 |
NEK10_TYR |
0.389 | 0.006 | 1 | 0.411 |
MST1R |
0.389 | -0.047 | 3 | 0.437 |
ALK |
0.388 | -0.013 | 3 | 0.371 |
FLT3 |
0.387 | -0.007 | 3 | 0.434 |
EPHA1 |
0.387 | -0.037 | 3 | 0.358 |
KIT |
0.387 | -0.024 | 3 | 0.418 |
LIMK2_TYR |
0.386 | -0.080 | -3 | 0.481 |
LTK |
0.386 | -0.034 | 3 | 0.376 |
EPHA7 |
0.385 | -0.049 | 2 | 0.269 |
TEK |
0.385 | -0.066 | 3 | 0.383 |
PDHK4_TYR |
0.384 | -0.133 | 2 | 0.325 |
FGFR4 |
0.383 | -0.030 | -1 | 0.389 |
WEE1_TYR |
0.382 | -0.043 | -1 | 0.375 |
LIMK1_TYR |
0.382 | -0.116 | 2 | 0.273 |
EPHA8 |
0.382 | -0.033 | -1 | 0.398 |
EPHA3 |
0.381 | -0.070 | 2 | 0.257 |
PINK1_TYR |
0.381 | -0.163 | 1 | 0.438 |
NTRK3 |
0.381 | -0.055 | -1 | 0.362 |
DDR1 |
0.381 | -0.131 | 4 | 0.427 |
FGFR1 |
0.381 | -0.076 | 3 | 0.386 |
PDGFRB |
0.381 | -0.073 | 3 | 0.450 |
FES |
0.379 | -0.024 | -1 | 0.492 |
NTRK2 |
0.379 | -0.065 | 3 | 0.396 |
PDGFRA |
0.379 | -0.070 | 3 | 0.462 |
EGFR |
0.379 | -0.035 | 1 | 0.337 |
ERBB2 |
0.379 | -0.065 | 1 | 0.420 |
INSRR |
0.378 | -0.065 | 3 | 0.383 |
EPHA5 |
0.377 | -0.069 | 2 | 0.274 |
MATK |
0.376 | -0.051 | -1 | 0.395 |
CSK |
0.376 | -0.065 | 2 | 0.262 |
INSR |
0.376 | -0.065 | 3 | 0.372 |
NTRK1 |
0.376 | -0.103 | -1 | 0.382 |
TNK1 |
0.375 | -0.109 | 3 | 0.418 |
MET |
0.375 | -0.049 | 3 | 0.396 |
JAK3 |
0.374 | -0.103 | 1 | 0.419 |
FGFR2 |
0.373 | -0.130 | 3 | 0.395 |
EPHA2 |
0.371 | -0.071 | -1 | 0.342 |
PTK2 |
0.371 | -0.053 | -1 | 0.278 |
FGFR3 |
0.367 | -0.118 | 3 | 0.378 |
IGF1R |
0.367 | -0.069 | 3 | 0.327 |
SYK |
0.367 | -0.056 | -1 | 0.283 |
KDR |
0.367 | -0.123 | 3 | 0.375 |
ERBB4 |
0.365 | -0.052 | 1 | 0.343 |
DDR2 |
0.364 | -0.106 | 3 | 0.375 |
MUSK |
0.364 | -0.074 | 1 | 0.352 |
FLT1 |
0.363 | -0.108 | -1 | 0.302 |
FLT4 |
0.357 | -0.149 | 3 | 0.374 |
ZAP70 |
0.350 | -0.058 | -1 | 0.217 |